A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma

NCT04665895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

451

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone propionate 100 mcg/blister oral inhalation powder/Respirent Pharmaceuticals
DRUG: FLOVENT DISKUS® 100 mcg/blister oral inhalation powder/GSK
DRUG: Placebo

Sponsor

Respirent Pharmaceuticals Co Ltd.

Collaborators

[object Object]